US Military to Join Ebola Fight

President Obama plans to send thousands of military personnel to Africa to streamline infectious disease-response efforts.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, ARMY MEDICINEThe number of people infected with Ebola virus is growing “exponentially,” according to the World Health Organization. To aid in relief efforts, the US military is gearing up for a greater presence in the hardest-hit African countries. President Obama announced details of the plan yesterday (September 17). “If the outbreak is not stopped now, we could be looking at hundreds of thousands of people affected, with profound economic, political and security implications for all of us,” Obama told reporters after briefings at the US Centers for Disease Control and Prevention (CDC) and Emory University in Atlanta, Georgia.

“The president considers this a top national security issue,” an anonymous government official told The Washingon Post on Monday (September 15). To contain and combat Ebola, “it’s going to be a whole government-wide response and he will call upon some additional assets to help him effect this mission,” the official continued.

The response will include a 3,000-person team based in Liberia that will coordinate the distribution of supplies and services. Additionally, engineers sent by the Pentagon will set up healthcare facilities and medical workers will train health care providers on the ground, according to a second article in the Post.

“This is a really significant response on the military side,” Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, told ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies